Search results
Oct 28, 2019 · David Hung, M.D., has had a strange few years: From the man who led Medivation to being snapped up by Pfizer in a major $14 billion M&A deal, he then went over to Axovant, where it went very...
David Hung, M.D. Founder, President and Chief Executive Officer Dr. Hung founded Nuvation Bio in 2018 and serves as President and Chief Executive Officer and member of the Board of Directors.
Jun 12, 2024 · T-Therapeutics appoints Dr David Hung as Chairman. Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of...
View David Hung, M.D.’s profile on LinkedIn, a professional community of 1 billion members. David is the founder, President and CEO of Nuvation Bio, a next-generation biotech company…
Biopharma industry veteran, founder of Medivation and serial entrepreneur Dr David Hung has become chairman of Cambridge biotech start-up T-Therapeutics. He will support development of the company’s pipeline of TCR-based immuno-oncology drugs.
Jun 12, 2024 · T-Therapeutics appoints Dr David Hung as Chairman. Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of...
Professor David Hung is Centre Director of Science of Learning in Education at the National Institute of Education (NIE), Nanyang Technological University (NTU), Singapore. He is also the President’s Chair in Learning Sciences.
